Actemra 200mg, a treatment known scientifically as tocilizumab, is a a potent pharmaceutical agent primarily used for the control of rheumatoid arthritis. This effective agent acts by inhibiting the activity of interleukin-6 (IL-6), a communication protein vital in the inflammatory process. Moreover, Actemra exhibits efficacy in the management of